Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Location status: Recruiting
Location contact
Maryanna Klatt, PhD
CONTACT
Maryanna Klatt, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06949943
This clinical trial tests how well guided meditation, compared to silence, works to reduce pre-operative anxiety in patients undergoing cancer-directed surgery. Pre-operative anxiety affects patient experience and has been found to be a predictor of severe post-operative pain and chronic pain after surgery, influencing the success and quality of a patient's recovery. While medication is often prescribed to improve anxiety symptoms, research has showed that mindfulness techniques can be used to decrease anxiety, improve comfort, and can impact both psychological and physiologic symptoms. Completing pre-operative guided meditation may work well to reduce pre-operative anxiety in patients undergoing cancer directive surgery.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Columbus, Ohio, 43210, United States
Location status: Recruiting
Maryanna Klatt, PhD
CONTACT
Maryanna Klatt, PhD
PRINCIPAL_INVESTIGATOR
PRIMARY OBJECTIVE:
I. To improve is pre-operative patient anxiety in surgical settings.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients listen to 10 minutes of guided meditation prior to surgery.
ARM II: Patients wear noise cancelling headphones for 10 minutes prior to surgery.
After completion of study intervention, patients are followed up for up to 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Listen to guided meditation
Other names: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments
Ancillary studies
Ancillary studies
Time frame: Pre and post intervention, approximately 10 minutes
Measured with the Patient Reported Outcome Measurement Information System Anxiety. PROMIS Anxiety short form is an 8-item scale used to assess anxiety in individuals 18 years or older. Each item is on a 5-point scale to be summed, with higher scores indicating greater anxiety.
Time frame: Pre and post intervention, approximately 10 minutes
Measured by a single-item visual analog scale. The single-item visual analog scale will be used to assess momentary anxiety. The item will ask, "On a scale of 1 to 10, how anxious do you feel right now?" and patients will rate the level of anxiety on a scale of 0 to 10 (0=not at all anxious, 10=extremely anxious).
Time frame: Up to 6 months post intervention
Will be extracted from the electronic medical record via chart review. Days of opioid use will be calculated and compared between intervention and control groups.
Time frame: Up to 6 months post intervention
Will be extracted from the electronic medical record via chart review. Daily morphine equivalent dose for each opioid prescribed will be calculated and compared between intervention and control groups.
Time frame: Up to 6 months post intervention
Will be extracted from the electronic medical record via chart review. Average daily morphine equivalent dose will be calculated and compared between intervention and control groups.
Time frame: Up to 6 months post intervention
Will be extracted from the electronic medical record via chart review.
Contact information is provided by the study sponsor or research team.
Ohio State University Comprehensive Cancer Center
Other
Enhancing Quality of Patient Experience Via an Innovative Reduction of Pre-Operative Anxiety
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT07235501
Graft Versus Host Disease, Graft vs Host Disease
Duarte, California, United States
View Trial DetailsNCT06513962
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Birmingham, Alabama, United States
View Trial DetailsNCT06941324
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Ann Arbor, Michigan, United States
View Trial Details